Skip to content

Evolus EOLS Gross Profit

Gross Profit at other companies

AbbVie logo
AbbVieABBV
$10.78B+15.4%

Segments

By segment

See full
Reportable Segment$48.9M+4.8%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's gross profit?
Evolus (EOLS) reported gross profit of $48.9M in Q1 2026.
How has Evolus's gross profit changed year-over-year?
Evolus's gross profit increased by 4.8% year-over-year, from $46.66M to $48.9M.
What is the long-term trend for Evolus's gross profit?
Over 4 years (2021 to 2025), Evolus's gross profit has grown at a 36.9% compound annual growth rate (CAGR), from $56.14M to $197.11M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.